Menarini (#473)
Laufzeit: 01.01.2013 - 31.12.2014
imported
Kurzfassung
Febuxostat for tumor lysis syndrome prevention in hematologic malignancies: a randomized, double blind, phase III study versus Allopurinol
Laufzeit: 01.01.2013 - 31.12.2014
Febuxostat for tumor lysis syndrome prevention in hematologic malignancies: a randomized, double blind, phase III study versus Allopurinol
